Drug
Tacrolimus Inhalation Aerosol
Tacrolimus Inhalation Aerosol: highest development phase Phase 2, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tacrolimus Inhalation Aerosol NCT00116103 | Phase 2 | Asthma |
Latest
No recent events.
Follow Tacrolimus Inhalation Aerosol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.